Daiwa Securities Group Inc. Concert Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$4.34 - $5.84 $837 - $1,127	193 New	193 $1,000
Q4 2021 Feb 03, 2022	SELL	$2.69 - $4.22 $156 - $244	-58 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$9.48 - $12.84 $549 - $744	58 New	58 $1,000
Q4 2019 Jan 31, 2020	SELL	$5.71 - $9.22 $719 - $1,161	-126 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$19.24 - $28.03 $2,424 - $3,531	126 New	126 $3,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.